hfa 2020: dapagliflozin and diuretic use in patients with hfref in dapa-hf — dr alice m jackson
Published 4 years ago • 1.9K plays • Length 6:57Download video MP4
Download video MP3
Similar videos
-
3:57
hfa 23: dapa-resist: dapagliflozin vs metolazone in patients with hf and diuretic resistance
-
6:53
hfa 2020: prospective analysis of dapa-hf — dr kieran docherty
-
3:35
hf 2022: deliver extends benefits of dapagliflozin to the full spectrum of pts with hf
-
3:48
hfa 23: dapagliflozin and peripheral arterial disease in heart failure
-
5:33
recent studies of sglt-2s in patients with hfref
-
4:20
hf 2022: clorotic: combined loop with thiazide diuretics in pts with decompensated hf | dr trullas
-
4:28
dapa-hf: substudy shows dapagliflozin reduces t2d risk in hf
-
3:50
dr. mcmurray discusses the dapa-hf trial of dapagliflozin in systolic heart failure
-
15:46
acc 2021: the dare-19 randomized trial
-
13:17
esc 2020 discussion: the dapa-ckd study — prof david wheeler & dr harriette van spall
-
5:30
esc 2019: dapa-hf - a perspective - prof giuseppe rosano
-
4:17
esc 2020: commentary on the dapa-ckd study — dr giuseppe galati
-
2:17
takeaways of dapa-hf: sglt2s for cvd
-
5:21
acc 23: evaluation of the mechanism of benefit for dapagliflozin in hfpef
-
13:30
aha 22: late-breaker discussion: the transform-hf trial
-
2:17
aha 2021: empatropism fe: effects of empagliflozin on iron metabolism in non-diabetic hf patients
-
2:38
aha 2021: emperor-preserved: empagliflozin, health status, & qol in patients with hfpef | dr butler
-
1:58
ep 18: effects of dapagliflozin on postprandial lipid metabolism in type 2 diabetes mellitus